{
    "clinical_study": {
        "@rank": "107878", 
        "acronym": "HALT-C", 
        "arm_group": [
            {
                "arm_group_label": "1", 
                "arm_group_type": "Experimental", 
                "description": "Peg-interferon alfa-2a 90 mcg/week"
            }, 
            {
                "arm_group_label": "2", 
                "arm_group_type": "Active Comparator", 
                "description": "Standard of care followup"
            }
        ], 
        "brief_summary": {
            "textblock": "The HALT-C Trial is a National Institute of Diabetes and Digestive and Kidney Diseases\n      sponsored, randomized clinical trial of long-term use of Peginterferon alfa-2a (pegylated\n      interferon) in patients who failed to respond to prior interferon treatment. All patients\n      who enter the trial will be treated for 6 months with Peginterferon alfa-2a and Ribavirin.\n      Patients who respond to this 6 month treatment will continue to be treated for an additional\n      6 months.\n\n      Patients who do not respond to this treatment will be eligible for the long-term maintenance\n      phase of this study where patients will be randomly selected to be treated with\n      Peginterferon alfa-2a or to discontinue treatment for 3.5 years. Patients in both arms of\n      this study will be followed closely with quarterly study visits.\n\n      The combination of peginterferon plus ribavirin has recently been approved by the FDA for\n      treatment of chronic HCV.  Patients who remain HCV-RNA positive after being treated for at\n      least 6 months with peginterferon and ribavirin outside of this study may be eligible to\n      directly enter the randomized portion of the HALT-C Trial.\n\n      The HALT-C study is designed to determine if continuing interferon long-term over several\n      years will suppress Hepatitis C virus, prevent progression to cirrhosis, prevent liver\n      cancer and reduce the need for liver transplantation."
        }, 
        "brief_title": "Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment", 
        "clinical_results": {
            "baseline": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "B1", 
                            "description": "Treatment with Peginterferon alfa-2a 90 mcg administered once weekly for an additional 42 months", 
                            "title": "Peginterferon Alfa-2a 90 Mcg/Week"
                        }, 
                        {
                            "@group_id": "B2", 
                            "description": "Stop any peginterferon alfa-2a/ribavirin therapy and followed prospectively for an additional 42 months without treatment", 
                            "title": "Standard of Care Followup"
                        }, 
                        {
                            "@group_id": "B3", 
                            "description": "Total of all reporting groups", 
                            "title": "Total"
                        }
                    ]
                }, 
                "measure_list": {
                    "measure": [
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "517"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "533"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "1050"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "param": "Number", 
                            "title": "Number of Participants", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "0"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "0"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "<=18 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "489"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "511"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "1000"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Between 18 and 65 years"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "28"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "22"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "50"
                                                }
                                            ]
                                        }, 
                                        "sub_title": ">=65 years"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Age", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@spread": "7.3", 
                                                "@value": "51.1"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@spread": "7.0", 
                                                "@value": "50.1"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@spread": "7.2", 
                                                "@value": "50.6"
                                            }
                                        ]
                                    }
                                }
                            }, 
                            "dispersion": "Standard Deviation", 
                            "param": "Mean", 
                            "title": "Age", 
                            "units": "years"
                        }, 
                        {
                            "category_list": {
                                "category": [
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "155"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "150"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "305"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Female"
                                    }, 
                                    {
                                        "measurement_list": {
                                            "measurement": [
                                                {
                                                    "@group_id": "B1", 
                                                    "@value": "362"
                                                }, 
                                                {
                                                    "@group_id": "B2", 
                                                    "@value": "383"
                                                }, 
                                                {
                                                    "@group_id": "B3", 
                                                    "@value": "745"
                                                }
                                            ]
                                        }, 
                                        "sub_title": "Male"
                                    }
                                ]
                            }, 
                            "param": "Number", 
                            "title": "Gender", 
                            "units": "participants"
                        }, 
                        {
                            "category_list": {
                                "category": {
                                    "measurement_list": {
                                        "measurement": [
                                            {
                                                "@group_id": "B1", 
                                                "@value": "517"
                                            }, 
                                            {
                                                "@group_id": "B2", 
                                                "@value": "533"
                                            }, 
                                            {
                                                "@group_id": "B3", 
                                                "@value": "1050"
                                            }
                                        ]
                                    }, 
                                    "sub_title": "United States"
                                }
                            }, 
                            "param": "Number", 
                            "title": "Region of Enrollment", 
                            "units": "participants"
                        }
                    ]
                }
            }, 
            "certain_agreements": {
                "pi_employee": "Principal Investigators are NOT employed by the organization sponsoring the study.", 
                "restrictive_agreement": "There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed."
            }, 
            "outcome_list": {
                "outcome": [
                    {
                        "description": "Progression of liver disease within 1400 days as indicated by death, hepatic decompensation (variceal hemorrhage; ascites; spontaneous bacterial peritonitis; hepatic encephalopathy), hepatocellular carcinoma, a Child-Turcotte-Pugh (CTP) score of 7 or more on two consecutive study visits (score range 5-15, higher score indicates greater decompensation), or for patients with noncirrhotic fibrosis at baseline, an increase in Ishak hepatic fibrosis score (range 0-6, higher score indicates greater fibrosis) of at least 2 points by assessment of a liver-biopsy specimen obtained during the study", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Treatment with Peginterferon alfa-2a 90 mcg administered once weekly for an additional 42 months", 
                                    "title": "Peginterferon Alfa-2a 90 Mcg/Week"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Stop any peginterferon alfa-2a/ribavirin therapy and followed prospectively for an additional 42 months without treatment", 
                                    "title": "Standard of Care Followup"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "447"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "452"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "157"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "157"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Progression of liver disease within 1400 days as indicated by death, hepatic decompensation (variceal hemorrhage; ascites; spontaneous bacterial peritonitis; hepatic encephalopathy), hepatocellular carcinoma, a Child-Turcotte-Pugh (CTP) score of 7 or more on two consecutive study visits (score range 5-15, higher score indicates greater decompensation), or for patients with noncirrhotic fibrosis at baseline, an increase in Ishak hepatic fibrosis score (range 0-6, higher score indicates greater fibrosis) of at least 2 points by assessment of a liver-biopsy specimen obtained during the study", 
                                    "param": "Number", 
                                    "title": "Progression of Liver Disease as Indicated by Death, Hepatic Decompensation, Hepatocellular Carcinoma, or for Patients With Noncirrhotic Fibrosis at Baseline, an Increase in the Ishak Hepatic Fibrosis Score of 2 or More Points", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "1400 days (3.85 years) post randomization", 
                        "title": "Progression of Liver Disease as Indicated by Death, Hepatic Decompensation, Hepatocellular Carcinoma, or for Patients With Noncirrhotic Fibrosis at Baseline, an Increase in the Ishak Hepatic Fibrosis Score of 2 or More Points", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "For patients with noncirrhotic fibrosis at baseline, an increase in Ishak hepatic fibrosis score (range 0-6, higher score indicates greater fibrosis) of at least 2 points by assessment of a liver-biopsy specimen obtained during the study (collected at Year 2 and Year 4 biopsies, 1.5 and 3.5 years after randomization)", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Treatment with Peginterferon alfa-2a 90 mcg administered once weekly for an additional 42 months", 
                                    "title": "Peginterferon Alfa-2a 90 Mcg/Week"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Stop any peginterferon alfa-2a/ribavirin therapy and followed prospectively for an additional 42 months without treatment", 
                                    "title": "Standard of Care Followup"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "447"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "452"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "64"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "70"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "For patients with noncirrhotic fibrosis at baseline, an increase in Ishak hepatic fibrosis score (range 0-6, higher score indicates greater fibrosis) of at least 2 points by assessment of a liver-biopsy specimen obtained during the study (collected at Year 2 and Year 4 biopsies, 1.5 and 3.5 years after randomization)", 
                                    "param": "Number", 
                                    "title": "Increase in Ishak Fibrosis Score by 2 Points or More at 2 or 4 Year Biopsies", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "1400 days (3.85 years) post randomization", 
                        "title": "Increase in Ishak Fibrosis Score by 2 Points or More at 2 or 4 Year Biopsies", 
                        "type": "Primary"
                    }, 
                    {
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Treatment with Peginterferon alfa-2a 90 mcg administered once weekly for an additional 42 months", 
                                    "title": "Peginterferon Alfa-2a 90 Mcg/Week"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Stop any peginterferon alfa-2a/ribavirin therapy and followed prospectively for an additional 42 months without treatment", 
                                    "title": "Standard of Care Followup"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "447"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "452"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "13"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "8"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Death From Any Cause", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "safety_issue": "Yes", 
                        "time_frame": "1400 days (3.85 years) post randomization", 
                        "title": "Death From Any Cause", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "A diagnosis of development of hepatocellular carcinoma (HCC) was based on either\nHistology showing HCC (from a biopsy, surgery, or autopsy) or\nA new hepatic defect on imaging with an alpha-fetoproteion (AFP) level rising to > 1,000 ng/ml.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Treatment with Peginterferon alfa-2a 90 mcg administered once weekly for an additional 42 months", 
                                    "title": "Peginterferon Alfa-2a 90 Mcg/Week"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Stop any peginterferon alfa-2a/ribavirin therapy and followed prospectively for an additional 42 months without treatment", 
                                    "title": "Standard of Care Followup"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "447"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "452"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "12"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "15"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "A diagnosis of development of hepatocellular carcinoma (HCC) was based on either\nHistology showing HCC (from a biopsy, surgery, or autopsy) or\nA new hepatic defect on imaging with an alpha-fetoproteion (AFP) level rising to > 1,000 ng/ml.", 
                                    "param": "Number", 
                                    "title": "Development of Hepatocellular Carcinoma (HCC)", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "1400 days (3.85 years) post randomization", 
                        "title": "Development of Hepatocellular Carcinoma (HCC)", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Child-Turcotte-Pugh (CTP) score of 7 or more on two consecutive study visits (score range 5-15, higher score indicates greater hepatic decompensation)", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Treatment with Peginterferon alfa-2a 90 mcg administered once weekly for an additional 42 months", 
                                    "title": "Peginterferon Alfa-2a 90 Mcg/Week"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Stop any peginterferon alfa-2a/ribavirin therapy and followed prospectively for an additional 42 months without treatment", 
                                    "title": "Standard of Care Followup"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "447"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "452"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "47"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "42"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Child-Turcotte-Pugh (CTP) score of 7 or more on two consecutive study visits (score range 5-15, higher score indicates greater hepatic decompensation)", 
                                    "param": "Number", 
                                    "title": "Child-Turcotte-Pugh (CTP) Score of 7 or Higher at Two Consecutive Study Visits", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "1400 days (3.85 years) post randomization", 
                        "title": "Child-Turcotte-Pugh (CTP) Score of 7 or Higher at Two Consecutive Study Visits", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "A gastrointestinal hemorrhage which is believed by the investigator to be due to bleeding esophageal or gastric varices.  In general, an endoscopy will have been performed and will have revealed either direct evidence of variceal bleeding (bleeding varix, red wale sign) or historical evidence for significant upper gastro-intestinal bleeding plus upper endoscopy revealing moderate varices and no other site of bleeding is identified", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Treatment with Peginterferon alfa-2a 90 mcg administered once weekly for an additional 42 months", 
                                    "title": "Peginterferon Alfa-2a 90 Mcg/Week"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Stop any peginterferon alfa-2a/ribavirin therapy and followed prospectively for an additional 42 months without treatment", 
                                    "title": "Standard of Care Followup"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "447"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "452"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "3"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "6"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "A gastrointestinal hemorrhage which is believed by the investigator to be due to bleeding esophageal or gastric varices.  In general, an endoscopy will have been performed and will have revealed either direct evidence of variceal bleeding (bleeding varix, red wale sign) or historical evidence for significant upper gastro-intestinal bleeding plus upper endoscopy revealing moderate varices and no other site of bleeding is identified", 
                                    "param": "Number", 
                                    "title": "Variceal Hemorrhage", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "1400 days (3.85 years) post randomization", 
                        "title": "Variceal Hemorrhage", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Any abdominal fluid which is:\nMild, moderate or marked on ultrasound; or\nProgressive on serial physical examinations; or\nRequires diuretic therapy. To meet the definition of ascites, abdominal fluid that is \u201cmild\u201d (\u201cbarely detectable\u201d) on physical examination requires ultrasound confirmation that is \u201cmild\u201d, \u201cmoderate\u201d or \u201cmarked\u201d ascites.  Ultrasound reports of minimal fluid around the liver do not meet the definition.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Treatment with Peginterferon alfa-2a 90 mcg administered once weekly for an additional 42 months", 
                                    "title": "Peginterferon Alfa-2a 90 Mcg/Week"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Stop any peginterferon alfa-2a/ribavirin therapy and followed prospectively for an additional 42 months without treatment", 
                                    "title": "Standard of Care Followup"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "447"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "452"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "13"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "8"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Any abdominal fluid which is:\nMild, moderate or marked on ultrasound; or\nProgressive on serial physical examinations; or\nRequires diuretic therapy. To meet the definition of ascites, abdominal fluid that is \u201cmild\u201d (\u201cbarely detectable\u201d) on physical examination requires ultrasound confirmation that is \u201cmild\u201d, \u201cmoderate\u201d or \u201cmarked\u201d ascites.  Ultrasound reports of minimal fluid around the liver do not meet the definition.", 
                                    "param": "Number", 
                                    "title": "Ascites", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "1400 days (3.85 years) post randomization", 
                        "title": "Ascites", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "Any episode of spontaneous ascitic infection diagnosed on the basis of elevated neutrophil count (> 250/ml) in paracentesis fluid or positive bacterial cultures and clinical diagnosis in the absence of white blood cell (WBC) availability.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Treatment with Peginterferon alfa-2a 90 mcg administered once weekly for an additional 42 months", 
                                    "title": "Peginterferon Alfa-2a 90 Mcg/Week"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Stop any peginterferon alfa-2a/ribavirin therapy and followed prospectively for an additional 42 months without treatment", 
                                    "title": "Standard of Care Followup"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "447"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "452"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "0"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "1"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Any episode of spontaneous ascitic infection diagnosed on the basis of elevated neutrophil count (> 250/ml) in paracentesis fluid or positive bacterial cultures and clinical diagnosis in the absence of white blood cell (WBC) availability.", 
                                    "param": "Number", 
                                    "title": "Spontaneous Bacterial Peritonitis", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "1400 days (3.85 years) post randomization", 
                        "title": "Spontaneous Bacterial Peritonitis", 
                        "type": "Primary"
                    }, 
                    {
                        "description": "A serious adverse event (SAE) is an untoward medical occurrence that results in any of the following:\nDeath\nIs life threatening (risk of death at the time of the event)\nRequires in-patient hospitalization or prolongation of existing hospitalization\nResults in persistent or significant disability/incapacity\nCongenital abnormality or birth defect\nTrial outcomes (except death) were not considered serious adverse events.", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Treatment with Peginterferon alfa-2a 90 mcg administered once weekly for an additional 42 months", 
                                    "title": "Peginterferon Alfa-2a 90 Mcg/Week"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Stop any peginterferon alfa-2a/ribavirin therapy and followed prospectively for an additional 42 months without treatment", 
                                    "title": "Standard of Care Followup"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "447"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "452"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "175"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "155"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "A serious adverse event (SAE) is an untoward medical occurrence that results in any of the following:\nDeath\nIs life threatening (risk of death at the time of the event)\nRequires in-patient hospitalization or prolongation of existing hospitalization\nResults in persistent or significant disability/incapacity\nCongenital abnormality or birth defect\nTrial outcomes (except death) were not considered serious adverse events.", 
                                    "param": "Number", 
                                    "title": "Serious Adverse Events", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "safety_issue": "Yes", 
                        "time_frame": "1400 days (3.85 years) post randomization", 
                        "title": "Serious Adverse Events", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Reduction in the dose of peginterferon alfa-2a factors:\nDisabling symptoms, which, in the opinion of the investigator, were related to peginterferon alfa-2a treatment and prevented the patient from performing his/her occupation or daily tasks.\nA rash consistent with allergic reaction or vasculitis.\nReductions in the platelet count according to protocol guidelines.\nA reduction in neutrophil count according to protocol guidelines.\nAny adverse reaction, which, in the opinion of the investigator, placed the patient at increased risk.", 
                        "posting_date": "10/2010", 
                        "safety_issue": "Yes", 
                        "time_frame": "1400 days (3.85 years) post randomization", 
                        "title": "Events Requiring Dose Reductions (in Both Treatment Groups).", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "For patients with noncirrhotic fibrosis at baseline, any change in Ishak hepatic fibrosis score (range 0-6, higher score indicates greater fibrosis) of at least 2 points by assessment of a liver-biopsy specimen obtained during the study (collected at Year 2 and Year 4 biopsies, 1.5 and 3.5 years after randomization)", 
                        "posting_date": "10/2010", 
                        "safety_issue": "No", 
                        "time_frame": "1400 days (3.85 years) post randomization", 
                        "title": "Changes in Fibrosis From Baseline at Year 2 or Year 4 Biopsy.", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Presumed HCC was considered when histology was not available and alpha-fetoprotein (AFP) is <1000 ng/ml, if:\nA new hepatic lesion was shown on ultrasound and 1 additional imaging showed a hepatic lesion with characteristics of HCC.\nAFP>ULN (upper limit of normal) and 2 imaging studies showed a hepatic lesion with characteristics of HCC.\nA progressively enlarging hepatic lesion starting as a new defect resulting in patient death.\nA new hepatic defect with at least 1 characteristic scan and:\nIncrease in size over time or\nIncreasing AFP rising to a level of >200 ng/ml", 
                        "posting_date": "10/2010", 
                        "safety_issue": "No", 
                        "time_frame": "1400 days (3.85 years) post randomization", 
                        "title": "Presumed Hepatocellular Carcinoma (HCC)", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "To measure health-related quality of life (HRQOL), we administered the highly reliable and validated Short Form Health Survey (SF-36) 43 at annual study visits.", 
                        "posting_date": "10/2010", 
                        "safety_issue": "No", 
                        "time_frame": "1400 days (3.85 years) post randomization", 
                        "title": "Quality of Life", 
                        "type": "Secondary"
                    }, 
                    {
                        "description": "Any mental status alteration which is deemed by the investigator to be due to portosystemic encephalopathy, whether occurring during a provoked episode (GI bleeding, diuretics, usual sedative doses), or spontaneously (without apparent cause).", 
                        "group_list": {
                            "group": [
                                {
                                    "@group_id": "O1", 
                                    "description": "Treatment with Peginterferon alfa-2a 90 mcg administered once weekly for an additional 42 months", 
                                    "title": "Peginterferon Alfa-2a 90 Mcg/Week"
                                }, 
                                {
                                    "@group_id": "O2", 
                                    "description": "Stop any peginterferon alfa-2a/ribavirin therapy and followed prospectively for an additional 42 months without treatment", 
                                    "title": "Standard of Care Followup"
                                }
                            ]
                        }, 
                        "measure_list": {
                            "measure": [
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "447"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "452"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "param": "Number", 
                                    "title": "Number of Participants", 
                                    "units": "participants"
                                }, 
                                {
                                    "category_list": {
                                        "category": {
                                            "measurement_list": {
                                                "measurement": [
                                                    {
                                                        "@group_id": "O1", 
                                                        "@value": "5"
                                                    }, 
                                                    {
                                                        "@group_id": "O2", 
                                                        "@value": "7"
                                                    }
                                                ]
                                            }
                                        }
                                    }, 
                                    "description": "Any mental status alteration which is deemed by the investigator to be due to portosystemic encephalopathy, whether occurring during a provoked episode (GI bleeding, diuretics, usual sedative doses), or spontaneously (without apparent cause).", 
                                    "param": "Number", 
                                    "title": "Hepatic Encephalopathy", 
                                    "units": "participants"
                                }
                            ]
                        }, 
                        "safety_issue": "No", 
                        "time_frame": "1400 days (3.85 years) post randomization", 
                        "title": "Hepatic Encephalopathy", 
                        "type": "Primary"
                    }
                ]
            }, 
            "participant_flow": {
                "group_list": {
                    "group": [
                        {
                            "@group_id": "P1", 
                            "description": "Treatment with Peginterferon alfa-2a 90 mcg administered once weekly for an additional 42 months", 
                            "title": "Peginterferon Alfa-2a 90 Mcg/Week"
                        }, 
                        {
                            "@group_id": "P2", 
                            "description": "Stop any peginterferon alfa-2a/ribavirin therapy and followed prospectively for an additional 42 months without treatment", 
                            "title": "Standard of Care Followup"
                        }
                    ]
                }, 
                "period_list": {
                    "period": {
                        "drop_withdraw_reason_list": {
                            "drop_withdraw_reason": {
                                "participants_list": {
                                    "participants": [
                                        {
                                            "@count": "70", 
                                            "@group_id": "P1"
                                        }, 
                                        {
                                            "@count": "81", 
                                            "@group_id": "P2"
                                        }
                                    ]
                                }, 
                                "title": "Withdrew or lost to follow-up"
                            }
                        }, 
                        "milestone_list": {
                            "milestone": [
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "517", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "533", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "STARTED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "#text": "70 Withdrew or were lost to followup; 158 Discontinued peginterferon but were followed", 
                                                "@count": "447", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "#text": "81 Withdrew or were lost to followup; 9 took peginterferon outside of protocol", 
                                                "@count": "452", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "COMPLETED"
                                }, 
                                {
                                    "participants_list": {
                                        "participants": [
                                            {
                                                "@count": "70", 
                                                "@group_id": "P1"
                                            }, 
                                            {
                                                "@count": "81", 
                                                "@group_id": "P2"
                                            }
                                        ]
                                    }, 
                                    "title": "NOT COMPLETED"
                                }
                            ]
                        }, 
                        "title": "Overall Study"
                    }
                }
            }, 
            "point_of_contact": {
                "email": "EverhartJ@extra.niddk.nih.gov", 
                "name_or_title": "James E. Everhart, MD, MPH, Project Officer", 
                "organization": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", 
                "phone": "301-594-8878"
            }, 
            "reported_events": {
                "desc": "In the treatment group, 3991 adverse events occurred among 486 patients, as compared with 3129 adverse events among 492 patients in the control group; 330 patients had at least one serious adverse event.", 
                "group_list": {
                    "group": [
                        {
                            "@group_id": "E1", 
                            "description": "Treatment with Peginterferon alfa-2a 90 mcg administered once weekly for an additional 42 months", 
                            "title": "Peginterferon Alfa-2a 90 Mcg/Week"
                        }, 
                        {
                            "@group_id": "E2", 
                            "description": "Stop any peginterferon alfa-2a/ribavirin therapy and followed prospectively for an additional 42 months without treatment", 
                            "title": "Standard of Care Followup"
                        }
                    ]
                }, 
                "other_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "486", 
                                                "@subjects_at_risk": "517"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "492", 
                                                "@subjects_at_risk": "533"
                                            }
                                        ], 
                                        "sub_title": "Total, other adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "26", 
                                                "@subjects_at_risk": "517"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "11", 
                                                "@subjects_at_risk": "533"
                                            }
                                        ], 
                                        "sub_title": "Anemia"
                                    }
                                }, 
                                "title": "Blood and lymphatic system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "42", 
                                                "@subjects_at_risk": "517"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "46", 
                                                "@subjects_at_risk": "533"
                                            }
                                        ], 
                                        "sub_title": "Hypertension"
                                    }
                                }, 
                                "title": "Cardiac disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "33", 
                                                "@subjects_at_risk": "517"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "56", 
                                                "@subjects_at_risk": "533"
                                            }
                                        ], 
                                        "sub_title": "Diabetes"
                                    }
                                }, 
                                "title": "Endocrine disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "42", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "39", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Chest pain"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "48", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "39", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Diarrhea, loose stool"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "52", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "34", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Nausea"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "42", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "31", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Dizziness, vertigo, light-headedness"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "77", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "44", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Headache"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "92", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "54", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Insomnia, sleep disturbance"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "58", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "37", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Memory loss, confusion"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "47", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "21", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Tingling, numbness"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "62", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "23", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Nervousness, irritability"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "34", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "22", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Nonproductive cough"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "26", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "18", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Dyspnea"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "71", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "45", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Rash"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "86", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "49", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Body aches, chills, fever"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "141", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "121", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Fatigue, malaise, weakness"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "63", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "64", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Localized edema"
                                        }
                                    ]
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "136", 
                                                "@subjects_at_risk": "517"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "134", 
                                                "@subjects_at_risk": "533"
                                            }
                                        ], 
                                        "sub_title": "Abdominal pain"
                                    }
                                }, 
                                "title": "Hepatobiliary disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "27", 
                                                "@subjects_at_risk": "517"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "23", 
                                                "@subjects_at_risk": "533"
                                            }
                                        ], 
                                        "sub_title": "Pneumonia"
                                    }
                                }, 
                                "title": "Immune system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "41", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "28", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Cystitis, bladder infection"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "26", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "13", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Pharyngitis"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "56", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "37", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Sinusitis"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "44", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "57", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Upper respiratory infection"
                                        }
                                    ]
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "136", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "119", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Arthralgia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "14", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "27", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Bursitis, tendonitis, enthesopathies"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "36", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "38", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Limb pain"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "52", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "32", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Muscle spasm"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "145", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "124", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Muscle/back aches or pain"
                                        }
                                    ]
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "27", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "29", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Anxiety"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "93", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "89", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Depression"
                                        }
                                    ]
                                }, 
                                "title": "Psychiatric disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "28", 
                                                "@subjects_at_risk": "517"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "12", 
                                                "@subjects_at_risk": "533"
                                            }
                                        ], 
                                        "sub_title": "Sexual dysfunction, impotence"
                                    }
                                }, 
                                "title": "Reproductive system and breast disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "27", 
                                                "@subjects_at_risk": "517"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "24", 
                                                "@subjects_at_risk": "533"
                                            }
                                        ], 
                                        "sub_title": "Bronchitis"
                                    }
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "93", 
                                                "@subjects_at_risk": "517"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "70", 
                                                "@subjects_at_risk": "533"
                                            }
                                        ], 
                                        "sub_title": "Pruritis"
                                    }
                                }, 
                                "title": "Skin and subcutaneous tissue disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment", 
                    "frequency_threshold": "5"
                }, 
                "serious_events": {
                    "category_list": {
                        "category": [
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "175", 
                                                "@subjects_at_risk": "517"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "155", 
                                                "@subjects_at_risk": "533"
                                            }
                                        ], 
                                        "sub_title": "Total, serious adverse events"
                                    }
                                }, 
                                "title": "Total"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Anemia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "0", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Thrombocytopenia or pancytopenia"
                                        }
                                    ]
                                }, 
                                "title": "Blood and lymphatic system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "16", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Atherosclerotic disease"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Arrhythmia"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Other cardiovascular or circulatory event"
                                        }
                                    ]
                                }, 
                                "title": "Cardiac disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Electrolyte, mineral, or water imbalance"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Diabetes and its complications"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Thyroid disease"
                                        }
                                    ]
                                }, 
                                "title": "Endocrine disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Nonvariceal gastrointestinal bleeding"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Hernia or intestinal obstruction"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "11", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "15", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Other digestive system event"
                                        }
                                    ]
                                }, 
                                "title": "Gastrointestinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "description": "These clinical signs and symptoms are not associated with a specific diagnosis but are still classified as a serious adverse event.", 
                                            "sub_title": "Cardiovascular signs or symptoms"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "description": "These clinical signs and symptoms are not associated with a specific diagnosis but are still classified as a serious adverse event.", 
                                            "sub_title": "Hepatobiliary signs or symptoms"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "description": "These clinical signs and symptoms are not associated with a specific diagnosis but are still classified as a serious adverse event.", 
                                            "sub_title": "Neurologic signs or symptoms"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "description": "These clinical signs and symptoms are not associated with a specific diagnosis but are still classified as a serious adverse event.", 
                                            "sub_title": "Digestive signs or symptoms"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "description": "These clinical signs and symptoms are not associated with a specific diagnosis but are still classified as a serious adverse event.", 
                                            "sub_title": "Other general signs or symptoms"
                                        }
                                    ]
                                }, 
                                "title": "General disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "13", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "15", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Gallbladder disease"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "7", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "5", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Other pancreatic or biliary disorders"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "description": "Liver-disease events not related to death or other study-related clinical primary or secondary outcomes of the trial", 
                                            "sub_title": "Liver-disease events other than primary or secondary outcomes"
                                        }
                                    ]
                                }, 
                                "title": "Hepatobiliary disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "16", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Mucocutaneous infection and infectious diseases"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "19", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "11", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Respiratory tract infections and infectious diseases"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Systemic infections and infectious diseases"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "15", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "19", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Other infections and infectious diseases"
                                        }
                                    ]
                                }, 
                                "title": "Infections and infestations"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Injury"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Drug reaction"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "11", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Liver-biopsy complication"
                                        }
                                    ]
                                }, 
                                "title": "Injury, poisoning and procedural complications"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "25", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "21", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Musculoskelatal surgery"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "9", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "6", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Arthritis or back pain"
                                        }
                                    ]
                                }, 
                                "title": "Musculoskeletal and connective tissue disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "10", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Malignant neoplasm"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Benign neoplasm"
                                        }
                                    ]
                                }, 
                                "title": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Cerebral aneurysm, infarct, or stroke"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "2", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Other neurologic event"
                                        }
                                    ]
                                }, 
                                "title": "Nervous system disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": [
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "8", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Affective disorders or delirium"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "4", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Suicidal ideation or attempt"
                                        }, 
                                        {
                                            "counts": [
                                                {
                                                    "@group_id": "E1", 
                                                    "@subjects_affected": "3", 
                                                    "@subjects_at_risk": "517"
                                                }, 
                                                {
                                                    "@group_id": "E2", 
                                                    "@subjects_affected": "1", 
                                                    "@subjects_at_risk": "533"
                                                }
                                            ], 
                                            "sub_title": "Substance abuse"
                                        }
                                    ]
                                }, 
                                "title": "Psychiatric disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "11", 
                                                "@subjects_at_risk": "517"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "8", 
                                                "@subjects_at_risk": "533"
                                            }
                                        ], 
                                        "sub_title": "Renal or urinary diseases"
                                    }
                                }, 
                                "title": "Renal and urinary disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "517"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "5", 
                                                "@subjects_at_risk": "533"
                                            }
                                        ], 
                                        "sub_title": "Gynecologic, menstrual, or sexual disorders"
                                    }
                                }, 
                                "title": "Reproductive system and breast disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "517"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "7", 
                                                "@subjects_at_risk": "533"
                                            }
                                        ], 
                                        "sub_title": "Respiratory disorders"
                                    }
                                }, 
                                "title": "Respiratory, thoracic and mediastinal disorders"
                            }, 
                            {
                                "event_list": {
                                    "event": {
                                        "counts": [
                                            {
                                                "@group_id": "E1", 
                                                "@subjects_affected": "0", 
                                                "@subjects_at_risk": "517"
                                            }, 
                                            {
                                                "@group_id": "E2", 
                                                "@subjects_affected": "2", 
                                                "@subjects_at_risk": "533"
                                            }
                                        ], 
                                        "sub_title": "Benign skin and nail disorders"
                                    }
                                }, 
                                "title": "Skin and subcutaneous tissue disorders"
                            }
                        ]
                    }, 
                    "default_assessment": "Systematic Assessment"
                }, 
                "time_frame": "Within 1400 days (3.83 years) after randomization"
            }
        }, 
        "completion_date": {
            "#text": "October 2009", 
            "@type": "Actual"
        }, 
        "condition": [
            "Chronic Hepatitis C", 
            "Cirrhosis, Liver", 
            "Fibrosis, Liver", 
            "Hepatic Cirrhosis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Fibrosis", 
                "Hepatitis", 
                "Hepatitis A", 
                "Hepatitis, Chronic", 
                "Hepatitis C", 
                "Liver Cirrhosis", 
                "Hepatitis C, Chronic"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age at entry at least 18 years.\n\n          -  Positive for Hepatitis C.\n\n          -  Previous treatment with any interferon or interferon and ribavirin for at least 3\n             months.\n\n          -  Documented non-response to treatment with interferon.\n\n          -  A liver biopsy demonstrating significant liver scarring.\n\n        Exclusion Criteria:\n\n          -  No other liver disease.\n\n          -  No unstable major medical diseases or conditions.\n\n          -  No major complications of cirrhosis.\n\n          -  No recent abuse of alcohol or illicit drugs."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "1050", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 8, 2000", 
        "firstreceived_results_date": "June 9, 2009", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_alias": "NCT00006139", 
            "nct_id": "NCT00006164", 
            "org_study_id": "HALT C", 
            "secondary_id": [
                "N01-DK-9-2328", 
                "N01-DK-9-2323", 
                "N01-DK-9-2324", 
                "N01-DK-9-2325", 
                "N01-DK-9-2326", 
                "N01-DK-9-2321", 
                "N01-DK-9-2327", 
                "N01-DK-9-2319", 
                "N01-DK-9-2318", 
                "N01-DK-9-2320", 
                "N01-DK-9-2322"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "1", 
                    "2"
                ], 
                "description": "Peginterferon alfa-2a 180 mcg/week injection, for 24 weeks, plus 1000-1200 mg Ribavirin oral (prescribed according to weight <75 kg, >75 kg) daily in two divided doses for 24 weeks", 
                "intervention_name": "Peginterferon alfa-2a + Ribavirin", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Pegasys (Hoffman-La Roche)", 
                    "Copegus (Hoffman-La Roche)"
                ]
            }, 
            {
                "arm_group_label": "1", 
                "description": "90 mcg/week injection, for 3.5 years", 
                "intervention_name": "Peginterferon alfa-2a", 
                "intervention_type": "Drug", 
                "other_name": "Pegasys (Hoffman-La Roche)"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Antiviral Agents", 
                "Ribavirin", 
                "Peginterferon alfa-2a", 
                "Interferon-alpha"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "liver disease", 
            "hepatitis c virus", 
            "antiviral agent", 
            "cirrhosis"
        ], 
        "lastchanged_date": "January 12, 2010", 
        "link": {
            "description": "HALT-C Web Site", 
            "url": "http://www.haltctrial.org"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Long Beach", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90822"
                    }, 
                    "name": "University of California-Irvine/VA Medical Center-Long Beach"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90033"
                    }, 
                    "name": "USC School of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Denver", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80262"
                    }, 
                    "name": "UCHSC (University of Colorado)"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Farmington", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06030"
                    }, 
                    "name": "University of Connecticut Health Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bethesda", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "20892-1800"
                    }, 
                    "name": "Lds, Niddk, Nih"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02114"
                    }, 
                    "name": "Massachusetts General Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Worcester", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "01655"
                    }, 
                    "name": "UMass Memorial HealthCare, University Campus"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ann Arbor", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48109"
                    }, 
                    "name": "University of Michigan"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63104"
                    }, 
                    "name": "Saint Louis University"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75390-9195"
                    }, 
                    "name": "University of Texas Southwestern - Dallas"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Richmond", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23298-0341"
                    }, 
                    "name": "Medical College of Virginia"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)", 
        "overall_official": [
            {
                "affiliation": "UCHSC (University of Colorado)", 
                "last_name": "Gregory T. Everson, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "St. Louis University", 
                "last_name": "Adrian M. Di Bisceglie, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "UTSW-Dallas", 
                "last_name": "William M. Lee, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "LDS, NIDDK, NIH", 
                "last_name": "Marc Ghany, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Massachusetts General Hospital", 
                "last_name": "Jules L. Dienstag, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Medical College of Virginia", 
                "last_name": "Mitchell Shiffman, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Michigan", 
                "last_name": "Anna Lok, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of California-Irvine/VA Medical Center-Long Beach", 
                "last_name": "Tim Morgan, M.D.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "USC School of Medicine", 
                "last_name": "Karen Lindsay, M.D., M.M.M.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "UMass Medical School", 
                "last_name": "Gyongyi Szabo, M.D., Ph.D.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "April 2007", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Progression of Liver Disease as Indicated by Death, Hepatic Decompensation, Hepatocellular Carcinoma, or for Patients With Noncirrhotic Fibrosis at Baseline, an Increase in the Ishak Hepatic Fibrosis Score of 2 or More Points", 
                "safety_issue": "No", 
                "time_frame": "1400 days (3.85 years) post randomization"
            }, 
            {
                "measure": "Increase in Ishak Fibrosis Score by 2 Points or More at 2 or 4 Year Biopsies", 
                "safety_issue": "No", 
                "time_frame": "1400 days (3.85 years) post randomization"
            }, 
            {
                "measure": "Death From Any Cause", 
                "safety_issue": "Yes", 
                "time_frame": "1400 days (3.85 years) post randomization"
            }, 
            {
                "measure": "Development of Hepatocellular Carcinoma (HCC)", 
                "safety_issue": "No", 
                "time_frame": "1400 days (3.85 years) post randomization"
            }, 
            {
                "measure": "Child-Turcotte-Pugh (CTP) Score of 7 or Higher at Two Consecutive Study Visits", 
                "safety_issue": "No", 
                "time_frame": "1400 days (3.85 years) post randomization"
            }, 
            {
                "measure": "Variceal Hemorrhage", 
                "safety_issue": "No", 
                "time_frame": "1400 days (3.85 years) post randomization"
            }, 
            {
                "measure": "Ascites", 
                "safety_issue": "No", 
                "time_frame": "1400 days (3.85 years) post randomization"
            }, 
            {
                "measure": "Spontaneous Bacterial Peritonitis", 
                "safety_issue": "No", 
                "time_frame": "1400 days (3.85 years) post randomization"
            }, 
            {
                "measure": "Hepatic Encephalopathy", 
                "safety_issue": "No", 
                "time_frame": "1400 days (3.85 years) post randomization"
            }
        ], 
        "reference": {
            "PMID": "15465617", 
            "citation": "Lee WM, Dienstag JL, Lindsay KL, Lok AS, Bonkovsky HL, Shiffman ML, Everson GT, Di Bisceglie AM, Morgan TR, Ghany MG, Morishima C, Wright EC, Everhart JE; HALT-C Trial Group. Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders. Control Clin Trials. 2004 Oct;25(5):472-92."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00006164"
        }, 
        "responsible_party": {
            "name_title": "James E. Everhart, MD, MPH, Project Officer", 
            "organization": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)"
        }, 
        "results_reference": {
            "PMID": "19052125", 
            "citation": "Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL; HALT-C Trial Investigators. Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med. 2008 Dec 4;359(23):2429-41."
        }, 
        "secondary_outcome": [
            {
                "measure": "Serious Adverse Events", 
                "safety_issue": "Yes", 
                "time_frame": "1400 days (3.85 years) post randomization"
            }, 
            {
                "measure": "Events Requiring Dose Reductions (in Both Treatment Groups).", 
                "safety_issue": "Yes", 
                "time_frame": "1400 days (3.85 years) post randomization"
            }, 
            {
                "measure": "Changes in Fibrosis From Baseline at Year 2 or Year 4 Biopsy.", 
                "safety_issue": "No", 
                "time_frame": "1400 days (3.85 years) post randomization"
            }, 
            {
                "measure": "Presumed Hepatocellular Carcinoma (HCC)", 
                "safety_issue": "No", 
                "time_frame": "1400 days (3.85 years) post randomization"
            }, 
            {
                "measure": "Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "1400 days (3.85 years) post randomization"
            }
        ], 
        "source": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                    "agency_class": "NIH"
                }, 
                {
                    "agency": "National Center on Minority Health and Health Disparities (NCMHD)", 
                    "agency_class": "NIH"
                }, 
                {
                    "agency": "National Cancer Institute (NCI)", 
                    "agency_class": "NIH"
                }, 
                {
                    "agency": "Hoffmann-La Roche", 
                    "agency_class": "Industry"
                }
            ], 
            "lead_sponsor": {
                "agency": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "June 2000", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "January 2010"
    }, 
    "geocoordinates": {
        "Lds, Niddk, Nih": "38.985 -77.095", 
        "Massachusetts General Hospital": "42.358 -71.06", 
        "Medical College of Virginia": "37.541 -77.436", 
        "Saint Louis University": "38.627 -90.199", 
        "UCHSC (University of Colorado)": "39.739 -104.985", 
        "UMass Memorial HealthCare, University Campus": "42.263 -71.802", 
        "USC School of Medicine": "34.052 -118.244", 
        "University of California-Irvine/VA Medical Center-Long Beach": "33.804 -118.158", 
        "University of Connecticut Health Center": "41.728 -72.84", 
        "University of Michigan": "42.281 -83.743", 
        "University of Texas Southwestern - Dallas": "32.803 -96.77"
    }
}